BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37020420)

  • 1. The impact of treatment resistance on outcome and course of electroconvulsive therapy in major depressive disorder.
    Rovers JJE; Vissers P; Loef D; van Waarde JA; Verdijk JPAJ; Broekman BFP; Vergouwen ACM; Oudega ML; van Exel E; Coenen R; Everaerd DS; Tendolkar I; Dols A; van Eijndhoven PFP
    Acta Psychiatr Scand; 2023 Jun; 147(6):570-580. PubMed ID: 37020420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): study protocol for a randomized non-inferiority trial of magnetic seizure therapy versus electroconvulsive therapy.
    Daskalakis ZJ; Tamminga C; Throop A; Palmer L; Dimitrova J; Farzan F; Thorpe KE; McClintock SM; Blumberger DM
    Trials; 2021 Nov; 22(1):786. PubMed ID: 34749782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonconvulsive Electrotherapy for Treatment Resistant Unipolar and Bipolar Major Depressive Disorder: A Proof-of-concept Trial.
    Regenold WT; Noorani RJ; Piez D; Patel P
    Brain Stimul; 2015; 8(5):855-61. PubMed ID: 26187603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electroconvulsive therapy in treatment resistant depression.
    Subramanian S; Lopez R; Zorumski CF; Cristancho P
    J Neurol Sci; 2022 Mar; 434():120095. PubMed ID: 34979372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of electroconvulsive therapy on cerebral monoamine oxidase A expression in treatment-resistant depression investigated using positron emission tomography.
    Baldinger-Melich P; Gryglewski G; Philippe C; James GM; Vraka C; Silberbauer L; Balber T; Vanicek T; Pichler V; Unterholzner J; Kranz GS; Hahn A; Winkler D; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Frey R; Lanzenberger R
    Brain Stimul; 2019; 12(3):714-723. PubMed ID: 30635228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Psychiatric polypharmacy and electroconvulsive therapy in treatment-resistant depression].
    Zöllner R; Huber MT; Mangelsdorf C; Konrad C; Zavorotnyy M
    Nervenarzt; 2020 Jul; 91(7):624-634. PubMed ID: 31489462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroconvulsive therapy for treatment-resistant depression.
    Hsieh MH
    Prog Brain Res; 2023; 281():69-90. PubMed ID: 37806717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ELEctroconvulsive therapy (ECT) vs. Ketamine in patients with Treatment-resistant Depression: The ELEKT-D study protocol.
    Mathew SJ; Wilkinson ST; Altinay M; Asghar-Ali A; Chang LC; Collins KA; Dale RM; Hu B; Krishnan K; Kellner CH; Malone DA; Murrough JW; Ostroff RB; Sanacora G; Shao M; Anand A
    Contemp Clin Trials; 2019 Feb; 77():19-26. PubMed ID: 30572160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Episodic memory following deep brain stimulation of the ventral anterior limb of the internal capsule and electroconvulsive therapy.
    Bergfeld IO; Mantione M; Hoogendoorn MLC; Horst F; Notten P; Schuurman PR; Denys D
    Brain Stimul; 2017; 10(5):959-966. PubMed ID: 28754306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative cognitive schema modification as mediator of symptom improvement after electroconvulsive therapy in major depressive disorder.
    Scheepens DS; van Waarde JA; Ten Doesschate F; Westra M; Kroes MCW; Schene AH; Schoevers RA; Denys D; Ruhé HG; van Wingen GA
    J Affect Disord; 2022 Aug; 310():156-161. PubMed ID: 35490877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood transcriptional response to treatment-resistant depression during electroconvulsive therapy.
    Israel-Elgali I; Hertzberg L; Shapira G; Segev A; Krieger I; Nitzan U; Bloch Y; Pillar N; Mayer O; Weizman A; Gurwitz D; Shomron N
    J Psychiatr Res; 2021 Sep; 141():92-103. PubMed ID: 34182381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depression.
    Zhong X; He H; Zhang C; Wang Z; Jiang M; Li Q; Zhang M; Huang X
    J Affect Disord; 2016 Sep; 201():124-30. PubMed ID: 27208499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT.
    Allen AP; Naughton M; Dowling J; Walsh A; Ismail F; Shorten G; Scott L; McLoughlin DM; Cryan JF; Dinan TG; Clarke G
    J Affect Disord; 2015 Nov; 186():306-11. PubMed ID: 26275358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant Effects of Electroconvulsive Therapy Unrelated to the Brain's Functional Network Connectivity alterations at an Individual Level.
    Chen GD; Ji F; Li GY; Lyu BX; Hu W; Zhuo CJ
    Chin Med J (Engl); 2017 Feb; 130(4):414-419. PubMed ID: 28218214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive Performance Under Electroconvulsive Therapy (ECT) in ECT-Naive Treatment-Resistant Patients With Major Depressive Disorder.
    Ziegelmayer C; Hajak G; Bauer A; Held M; Rupprecht R; Trapp W
    J ECT; 2017 Jun; 33(2):104-110. PubMed ID: 28169947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RETRACTED: Electroconvulsive therapy and aerobic exercise training increased BDNF and ameliorated depressive symptoms in patients suffering from treatment-resistant major depressive disorder.
    Salehi I; Hosseini SM; Haghighi M; Jahangard L; Bajoghli H; Gerber M; Pühse U; Kirov R; Holsboer-Trachsler E; Brand S
    J Psychiatr Res; 2014 Oct; 57():117-24. PubMed ID: 25073431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polygenic risk scores of lithium response and treatment resistance in major depressive disorder.
    Xiong Y; Karlsson R; Song J; Kowalec K; Rück C; Sigström R; Jonsson L; Clements CC; Andersson E; Boberg J; Lewis CM; Sullivan PF; Landén M; Lu Y
    Transl Psychiatry; 2023 Sep; 13(1):301. PubMed ID: 37770441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiomics and blood-based biomarkers of electroconvulsive therapy in severe and treatment-resistant depression: study protocol of the DetECT study.
    von Mücke-Heim IA; Pape JC; Grandi NC; Erhardt A; Deussing JM; Binder EB
    Eur Arch Psychiatry Clin Neurosci; 2024 Apr; 274(3):673-684. PubMed ID: 37644215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical factors related to acute electroconvulsive therapy outcome for patients with major depressive disorder.
    Chen CC; Lin CH; Yang WC; Chen MC
    Int Clin Psychopharmacol; 2017 May; 32(3):127-134. PubMed ID: 28177952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Executive function in treatment-resistant depression before and after electroconvulsive therapy.
    Stojanovic Z; Andric S; Soldatovic I; Dolic M; Spiric Z; Maric NP
    World J Biol Psychiatry; 2017 Dec; 18(8):624-632. PubMed ID: 27072874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.